In recent years, several clinical cohort studies have shown that the body TMAO levels are closely related to T2DM, and animal studies have found that TMAO can aggravate impaired glucose tolerance and hyperglycemia by blocking liver insulin signaling and promoting an adipose tissue inflammatory response.27 This evidence concerns the gene INS and Impaired glucose tolerance.